| ［1］ |
Wallack M K，Wolf J A Jr.，Bedwinek J，et al.Gestational carcinoma of the female breast.J Curr Probl Cancer，1983，7：1-58.
|
| ［2］ |
Pommier R F，Fields S A.Breast cancer in pregnancy-a diagnostic and therapeutic challenge.West J Med，1995，163：70-71.
|
| ［3］ |
Rossouw J E，Anderson G L，Prentice R L，et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women：principal results from the women's health initiative randomized controlled trial.JAMA，2002，288：321333.
|
| ［4］ |
Pathak D R.Dual effect of first full term pregnancy on breast cancer risk：empirical evidence and postulated underlying biology.Cancer Causes Control，2002，3：295-298.
|
| ［5］ |
Gottardis M M，Wagner R J，Borden E C，et al.Differential ability of antiestrogens to stimulate breast cancer cell（MCF-7）growth in vivo and in vitro.Cancer Res，1989，49：4765-4769.
|
| ［6］ |
Thorne C，Lee A V.Cross talk between estrogen receptor and IGF signaling in normal mammary gland development and breast cancer.Breast Dis，2003，17：105-114.
|
| ［7］ |
Burtrum D，Zhenping Z，Dan L，et al.A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks liganddependent signaling and inhibits human tumor growth in vivo.Cancer Res，2003，63：8912-8921.
|
| ［8］ |
Middleton L P，Amin M，Gwyn K，et al.Breast carcinoma in pregnant women：assessment of clinicopathologic and immunohistochemical features.Cancer，2003，98：1055-1060.
|
| ［9］ |
Petrek J A，Dukoff R，Rogatko A.Prognosis of pregnancy associated breast cancer.J Cancer，1991，67：869-872.
|
| ［10］ |
Shousha S.Breast carcinoma presenting during or shortly after pregnancy and lactation.Arch Pathol Lab Med，2000，124：1053-1060.
|
| ［11］ |
Elledge R M，Ciocca D R，Langone G，et al.Estrogen receptor，progesterone receptor，and HER-2/neu protein in breast cancers from pregnant patients.Cancer，1993，71：2499-2506.
|
| ［12］ |
Bonner P，Romain S，Marie J D，et al.Influence of pregnancy on the outcome of breast cancer：a case-control study.Int J Cancer，1997，72：720-727.
|
| ［13］ |
Berry D L，Theriault R L，Holemes F A，et al.Management of breast cancer during pregnancy using a standardized protocol.J Clin Oncol，1999，17：855-861.
|
| ［14］ |
Ring A E，Smith I E，Jones A，et al.Chemotherapy for breast cancer during pregnancy：18 year experience from five London teaching hospitals.J Clin Oncol，2005，23：4192-4197.
|
| ［15］ |
Middleton L P，Amin M，Gwyn K，et al.Breast carcinoma in pregnant women：assessment of clinicopathologic and immunohistochemical features.Cancer，2003，98：1055-1060.
|
| ［16］ |
Max M H，Klamer T W.Pregnancy and breast cancer.J South Med J，1983，76：1088-1090.
|
| ［17］ |
Chen J Y，Un Y，You L，et al.Diagnosis and multidisciplinary treatment of 9 cases of pregnancy-associated breast cancer.J China Oncol，2001，11：453-455.
|
| ［18］ |
Nicklas A H，Baker M E.Imaing strategies in the pregnant cancer patient.Semin Oncol，2000，27：623-632.
|
| ［19］ |
Ahn B Y，Kim H H，Moon W K，et al.Pregnancy and lactationassociated breast cancer：mammaographic and sonographic findings.J Ulatrasound Med，2003，22：491-497.
|
| ［20］ |
Mitre B K，Kanbour A I，Mauser N.Fine needle aspiration biopsy of breast carcinoma in pregnancy and lactation.J Acta Cytol，1997，41：1121-1130.
|
| ［21］ |
Petrek J A.Breast cancer during pregnancy.Cancer，1994，74：518-527.
|
| ［22］ |
Osei E K，Faulkner K.Fetal doses from radiological examinations.Br J Radiol，1999，72：773-780.
|
| ［23］ |
Medical devices agency.U.K.pregnancy and MR exposure.Guidelines for magnetic resonance equipment in clinical use.London：Medical Devices Agency，2002：22-23.
|
| ［24］ |
Mazze R I，Kallen B.Reproductive outcome after anaesthesia and operation during pragancy：a registry study of 5405 cases.Am J Obstet Gynecol，1989，161：1178-1185.
|
| ［25］ |
Doll D C，Ringenberg Q S，Yarbro J W.Antineoplastic agents and pregnancy.Semin Oncol，1989，16：337-346.
|
| ［26］ |
Giacalone P L，Laffargue F，Benos P.Chemotherapy for breast carcinoma during pregnancy：A French national survey.Cancer，1999，86：2266-2272.
|
| ［27］ |
Hahn K M，Johnson P H，Gordon N，et al.Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.Cancer，2006，107：1219-1226.
|
| ［28］ |
Cuvier C，Espie M，Extra J M，et al.Vinorelbine in pregnancy.Eur J Cancer，1997，33：168-169.
|
| ［29］ |
Sood A K，Shahin M S，Sorosky J I.Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy.Gynecol Oncol，2001，83：599-600.
|
| ［30］ |
Gadducci A，Cosio S，Fanucchi A，et al.Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy：case report and review of the literature.Anticancer Res，2003，23：5225-5230.
|
| ［31］ |
DeSantis M，Lucchese A，DeCarolis S，et al.Metastatic breast cancer in pregnancy：first case of chemotherapy with docetaxel.Eur J Cancer Care（Engl），2000，9：235-237.
|
| ［32］ |
Greskovich J F Jr，Macklis R M.Radiation therapy in pregnancy：risk calculation and risk minimization.Semin Oncol，2000，27：633-645.
|
| ［33］ |
Antypas C，Sandilos P，Kouvaris J，et al.Fetal dose evaluation during breast cancer radiotherapy.Int J Radiat Oncol Phys，1998，40：995-999.
|
| ［34］ |
Otake M，Schull W J，Lee S.Threshold for radiation-ralated severe mental retardation in prenatally exposed A-bomb sruviors：a rea-nalysis.Int J Radiat Biol，1996，70：755-763.
|
| ［35］ |
Mayr N A，Wen B C，Saw C B.Radiation therapy during pregnancy.Obstet Gynecol Clin North Am，1998，25：301-321.
|
| ［36］ |
Puckridge P J，Saunders C M，Ives A D，et al.Breast cancer and pregnancy：a diagnostic and management dilemma.ANZ J Surg，2003，73：500-503.
|
| ［37］ |
Saunders C M.Breast cancer in pregnancy//Shaugn O'Brien P，Maclean A eds.Hormones and cancer.London：Royal College of Obstetricians and Gynaecologists Press，1999：312-321.
|
| ［38］ |
Tewari K，Bonebrake R G，Asrat T，et al.Ambiguous genitalia in infant exposed to tamoxifen in utero.Lancet，1997，350：183.
|
| ［39］ |
Cullen S L，Pridjian G，Sutherland C M.Goldenhar's syndrome associated with tamoxifen given to the mother during gestation.JAMA，1994，271：1905-1906.
|
| ［40］ |
Slamon D J，Leyland Jones B，Shak S，et al.Use of chemotherapy plus a monoclonal antibody against HER-2 for metastatic breast cancer that overexpresses HER-2.N Engl J Med，2001，344：783-792.
|
| ［41］ |
Arnim A B，Dietmar S，Karl F T，et al.Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.Lancet Oncol，2007，8：79-81.
|
| ［42］ |
Dunlop D J，Soukop M，McEwan H P.Antenatal administration of aminopropylidene diphosphonate.Ann Rheum Dis，1990，49：555.
|
| ［43］ |
Illidge T M，Hussy M，Godden C W.Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pami dronate.Clin Oncol（R Coll Radiol），1996，8：257-258.
|
| ［44］ |
White T T.Carcinoma of the breast and pregnancy；analysis of 920 cases collected from the literature and 22 cases.Ann Surg，1954，139：9-18.
|
| ［45］ |
Bladstrom A，Anderson H，Olsson H.Worse survival in breast cancer among women with recent childbirth：results from a Swedish population-based register study.Clin Breast Cancer，2003，4：280-285.
|
| ［46］ |
Ishida T，Yokoe T，Kasumi F.Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation：analysis of case-control study in Japan.Jpn J Cancer Res，1992，83：1143-1149.
|
| ［47］ |
Zhang J，Liu G，Wu J，et al.Pregnancy-associated breast cancer：a case control and long-term follow-up study in China.J Exp Clin Cancer Res，2003，22：23-27.
|
| ［48］ |
Anderson B 0，Petrek J A，Byrd D R，et al.Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger.Am J Obstet Gynecol，1996，3：204-211.
|
| ［49］ |
Schedin P.Pregnancy-associated breast cancer and metastasis.Nat Rev Cancer，2006，6：281-291.
|
| ［50］ |
Helewa M，Levesque P，Provencher D，et al.Breast cancer pregnancy，and breastfeeding.J Obster Gynaecol Can，2002，24：164-180.
|